AlphaYouMU
Insider selling
Marshall Urist sold $726K of Royalty Pharma plc (RPRX) stock
Marshall Urist, EVP, Research & Investments of Royalty Pharma plc (RPRX), sold 13,684 shares of RPRX stock worth $726K, per an SEC Form 4 filed May 15, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 14, 2026, 1 day before it was made public.
RPRX has moved +9.4% since the trade date, from $53.40 to $58.44 (Sep 21, 2026 close).
- Traded
- May 14, 2026
- Disclosed
- May 15, 2026
- Filing delay
- 1 day
- Price since
- +9.4%
- Role
- EVP, Research & Investments
- Source
- SEC Form 4
More RPRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.